台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    65.0
  • 漲跌
    ▼2.3
  • 漲幅
    -3.42%
  • 成交量
    434
  • 產業
    上櫃 生技醫療類股
  • 73人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-富邦-北港 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1402/2803/1203/2404/0604/1604/2805/0805/10405060708090Jul '24Sep '24Nov '24Jan '25Mar '25May '2560d90dAll

富邦-北港 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/09366.2000.0065.0034950.61%
2025/05/0800.00365.2067.30-3491-0.61%
2025/05/0700.000.165.0065.90-0.1481-0.02%
2025/05/0200.00561.5661.80-5470-1.06%
2025/04/302.160.5300.0059.602.14700.45%
2025/04/29362.0000.0062.5034640.65%
2025/04/21358.9000.0058.0034750.63%
2025/04/1500.00360.4060.10-3490-0.61%
2025/04/09354.0000.0051.2034910.61%
2025/03/1100.00378.2081.50-3557-0.54%
2025/03/1000.00274.6576.80-2518-0.39%
2025/03/03369.6000.0069.6034830.62%
2025/02/2700.000.466.5666.20-0.4478-0.08%
2025/02/250.268.0000.0067.700.25030.04%
2025/02/240.268.10367.4068.00-2.8504-0.56%
2025/02/21167.701168.2567.80-10508-1.97%
2025/02/20470.55469.6071.0004970.00%
2025/02/1900.00865.4065.50-8490-1.63%
2025/02/12364.0000.0061.9035850.51%
2025/01/2200.001060.5060.90-10604-1.65%
2025/01/1400.00161.0062.90-1621-0.16%
2025/01/13167.001167.0562.80-10627-1.59%
2025/01/10565.0000.0065.4056240.80%
2025/01/09261.5000.0061.2026170.32%
2024/12/31163.7000.0064.3016690.15%
2024/12/261969.9100.0066.60196922.74%
2024/12/25773.17275.3574.0056830.73%
2024/12/2000.00160.8060.40-1684-0.15%
2024/12/19665.5700.0062.7066950.86%
2024/12/0900.00462.2562.00-4646-0.62%
2024/11/27166.8000.0066.5016770.15%
2024/11/25171.000.372.0071.900.76810.10%
2024/11/220.174.7000.0073.000.16720.01%
2024/11/21267.30367.2068.00-1662-0.15%
2024/11/19367.8000.0067.4036670.45%
2024/11/150.269.10370.1066.00-2.8678-0.41%
2024/11/14369.0000.0069.0036700.45%
2024/11/13266.20264.4064.0006520.00%
2024/11/12263.4000.0070.0026320.32%
2024/11/1100.00270.1070.10-2606-0.33%
2024/11/0800.00278.0077.80-2603-0.33%
2024/10/2800.00194.8095.50-1688-0.15%
2024/10/142121.0000.00121.0028170.24%
2024/10/0900.003122.00119.00-3838-0.36%
2024/10/073108.5000.00116.5038300.36%
2024/09/231163.5000.00158.0017940.13%
2024/09/1900.001178.50177.00-1785-0.13%
2024/09/1300.001176.50178.00-1779-0.13%
2024/09/1100.0030173.50185.00-30792-3.78%
2024/08/271220.0000.00220.0017850.13%
2024/08/2200.001222.00221.50-1798-0.13%
2024/08/211227.0000.00225.0018020.12%
2024/08/1300.001194.50189.00-1843-0.12%
2024/08/121204.000.5204.00198.000.58350.06%
2024/08/0900.004198.50203.50-4824-0.49%
2024/08/0800.001187.00187.00-1794-0.13%
2024/08/0100.001171.50175.50-1732-0.14%
2024/07/312157.001161.00161.0017270.14%
2024/07/292146.0000.00141.5027080.28%
2024/07/2300.001154.50160.00-1685-0.15%
2024/07/1913195.422180.75182.00116501.69%
2024/07/1821196.122196.75196.50196113.11%
2024/07/173179.0000.00191.0035890.51%
2024/07/1212.5161.5700.00162.0012.55442.30%
2024/07/1100.004149.00149.00-4531-0.75%
2024/06/174106.7500.00108.0043531.13%
2024/05/2800.00399.00100.00-3312-0.96%
2024/05/2700.001100.00100.00-1307-0.33%
2024/05/2100.00287.8093.00-2250-0.80%
2024/05/20285.80185.0086.3012380.42%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音